Tg Therapeutics Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Tg Therapeutics Inc inventory turnover ratio, the Tg Therapeutics Inc 's ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 1.03 in the second quarter 2026, a new company high. Average inventory processing period, for the Tg Therapeutics Inc in Jun 30 2026 quarter, has decreased to 354 days, compare to 429 days, in the Mar 31 2026 quarter.

Within Healthcare sector 309 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the II Quarter 2026, to 1867, from total ranking in the first quarter 2026 at 2110.

TGTX Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Tg Therapeutics Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

TGTX Inventory Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Inventory Growth	-4.66 %	-18.21 %	13.7 %	73.56 %	91.03 %
Y / Y Cost of Sales Growth	117.52 %	115.62 %	147.68 %	200.75 %	128.06 %
Inventory Turnover Ratio (TTM)	1.03	0.85	0.69	0.55	0.47
TGTX's Total Ranking	# 1867	# 2110	# 1976	# 1995	# 2004
Average inventory processing period	356	428	530	668	783
Seq. Inventory Growth	14.68 %	2.74 %	-14.54 %	-5.32 %	-1.62 %
Seq. Cost of Sales Growth	22.93 %	-12.14 %	35.77 %	48.34 %	21.86 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 90
Healthcare Sector	# 310
Overall Market	# 1867

Inventory Turnover Ratio Statistics
High	Average	Low
1.03	0.56	0.41
(Jun 30 2026)		(Mar 31 2024)

TGTX Company Profile >> Back to TGTX Efficiency Comparisons >> Compare TGTX Inventory Turnover Ratio to its Competitors

Financial Statements
Tg Therapeutics Inc 's Inventories	$ 148 Millions	Visit TGTX's Balance sheet
Tg Therapeutics Inc 's Cost of Revenues TTM	$ 141 Millions	Visit TGTX's Income Statement
What are TGTX's Sales?		Visit TGTX's Sales by Segment

Other Inventory Turnover Ratios
Tg Therapeutics Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
TGTX's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for TGTX's Competitors
Inventory Turnover Ratio for TGTX's Suppliers
Inventory Turnover Ratio for TGTX's Customers

You may also want to know
TGTX's Sales Growth Rates	TGTX's Pe Price to earnings ratio	TGTX's Receivables Turnover Ratio	TGTX's Stock Quote
TGTX's Net Income Growth Rates	TGTX's Ps Price to Sales ratio	TGTX's Sales per Employee	TGTX's Asset Turnover Ratio
TGTX's Net Margin	TGTX's Pb Price to Book ratio	TGTX's Financial Strength Ratios	TGTX's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Jun 30 2026	Inventories at quarter ending Jun 30 2026
International Stem Cell Corporation	2.61	$ 4.285 Millions	$ 2 Millions
Biomerica Inc	2.59	$ 4.091 Millions	$ 2 Millions
Evofem Biosciences Inc	2.58	$ 4.418 Millions	$ 2 Millions
Indivior Pharmaceuticals Inc	2.55	$ 240.000 Millions	$ 94 Millions
Nephros Inc	2.54	$ 8.991 Millions	$ 4 Millions
Illumina Inc	2.52	$ 1,510.000 Millions	$ 599 Millions
IMPACT BIOMEDICAL INC.	2.46	$ 0.414 Millions	$ 0 Millions
Quidelortho Corp	2.45	$ 1,481.500 Millions	$ 605 Millions
Perrigo Company Plc	2.43	$ 2,775.900 Millions	$ 1,140 Millions
Pro dex Inc	2.43	$ 53.213 Millions	$ 22 Millions
Angiodynamics Inc	2.43	$ 142.834 Millions	$ 59 Millions
Cytosorbents Corporation	2.43	$ 10.584 Millions	$ 4 Millions
Journey Medical Corp	2.42	$ 23.556 Millions	$ 10 Millions
Aquestive Therapeutics Inc	2.42	$ 17.828 Millions	$ 7 Millions
Viatris Inc	2.41	$ 9,604.200 Millions	$ 3,993 Millions
Electrocore Inc	2.40	$ 4.346 Millions	$ 2 Millions
United Therapeutics Corporation	2.39	$ 437.200 Millions	$ 183 Millions
Cannapharmarx Inc	2.37	$ 2.483 Millions	$ 1 Millions
Aurinia Pharmaceuticals Inc	2.34	$ 30.036 Millions	$ 13 Millions
Fortress Biotech Inc	2.34	$ 22.768 Millions	$ 10 Millions
Scientific Industries Inc	2.33	$ 4.057 Millions	$ 2 Millions
Resmed Inc	2.33	$ 2,176.428 Millions	$ 933 Millions
Insight Molecular Diagnostics Inc	2.31	$ 0.868 Millions	$ 0 Millions
Tela Bio Inc	2.30	$ 26.348 Millions	$ 11 Millions
Sanara Medtech Inc	2.29	$ 7.981 Millions	$ 3 Millions
China Pharma Holdings Inc	2.25	$ 3.450 Millions	$ 2 Millions
Beta Bionics Inc	2.23	$ 50.111 Millions	$ 22 Millions
Apyx Medical Corp	2.21	$ 21.014 Millions	$ 10 Millions
Medtronic Plc	2.21	$ 13,136.000 Millions	$ 5,950 Millions
Embecta Corp	2.19	$ 418.400 Millions	$ 191 Millions

Date modified: 2026-09-09T22:26:19+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.